FTC Seeks More Info On $3.4B Grifols-Talecris Deal
The Federal Trade Commission is seeking additional information on Spanish health care company Grifols SA's $3.4 billion plan to buy Talecris Biotherapeutics Holdings Corp., about a year after the agency blocked...To view the full article, register now.
Already a subscriber? Click here to view full article